Analyst Ratings for Emergent BioSolutions (EBS)
EBS Rating Summary
EBS Price Target Summary
- Highest: $12.00 (Benchmark)
- Lowest: $12.00 (Benchmark)
- Average: $12.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.00 (+57.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/30/2024 | H.C. Wainwright » Updated 4/29/2026 |
Raghuram Selvaraju | New Coverage | Buy (N/A) |
12.00 (N/A) |
8.27 (7.63) |
-7.74% | Details |
| 8/22/2024 | Rodman & Renshaw | N/A | New Coverage | Buy (N/A) |
16.00 (N/A) |
10.49 (7.63) |
-27.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
